FAMILY AND NEIGHBORS MOURN WOMAN SHOT BY ICE AGENT AFTER MAKING MINNEAPOLIS HER HOME. (PHOTO).

Image
 Family and neighbors mourn woman shot by ICE agent after making Minneapolis her home  Before she was fatally shot by a U.S. Immigration and Customs Enforcement officer, 37-year-old Renee Good had just dropped her youngest child off at an elementary school in Minneapolis, the city she and her family had recently begun to call home. As Trump administration officials continued Thursday to describe Good as a domestic terrorist who tried to ram federal agents with her Honda Pilot, those who knew her remembered someone very different: a gentle, kind, and openhearted mother, wife, and neighbor. Good, her wife and her 6-year-old son had recently moved from Kansas City, Missouri, to a quiet Minneapolis neighborhood lined with older homes and small apartment buildings. Some front porches were still decorated with pride flags and lingering holiday lights. In the days following her death, neighbors grew weary of media attention. One handwritten sign taped to a front door read, “NO MEDIA ...

GSK CEO TO RESIGN BY THE END OF THE YEAR. (PHOTO).


 GSK CEO to resign by the end of the year

GSK Chief Executive Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down on Dec. 31 after more than eight years at the helm of the London-based drugmaker.

Walmsley, 56, will be succeeded by Luke Miels, currently GSK’s chief commercial officer, the company announced Monday. During her tenure, Walmsley oversaw several strategic initiatives, including the spinoff of the consumer health business Haleon, but the company’s overall performance has underwhelmed investors. GSK shares rose 3.3% to 1,534.50 pence in early trading, making it the top gainer on the London Stock Exchange.

Despite these gains, GSK’s stock has fallen 11% since Walmsley took over on April 1, 2017. Analysts say the company has delivered on financial guidance but continues to experience slow growth. Derren Nathan, head of equity research at U.K.-based Hargreaves Lansdown, noted that while GSK has achieved progress, “the share price performance has been lackluster” and growth rates remain in the single digits.

Comments

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

TINUBU ANNOUNCES ARRIVAL OF 4 U.S ATTACK HELICOPTERS. (PHOTO).